JUST IN - Pfizer signs $6 billion licensing deal with China's 3SBio Inc to develop and manufacture lung, colorectal, and gynecological cancer drug.
#china #pfizer
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content. See T&Cs. 